(TRNS) Transcat - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8935291075
TRNS: Services, Instruments, Calibration, Repair, Distribution
Transcat, Inc. operates as a leading provider of calibration and laboratory instrument services across the United States, Canada, and international markets. The company is structured into two primary business segments: Service and Distribution. The Service segment delivers a comprehensive suite of offerings, including calibration, repair, inspection, analytical qualification, and preventative maintenance. Additionally, it provides consulting services and operates proprietary systems like CalTrak, a workflow management tool designed to streamline operations for both its service centers and clients. The segment also offers a secure online portal, Compliance, Control and Cost, which enables customers to manage assets and maintain calibration records digitally. This portal enhances operational efficiency and ensures regulatory compliance for its clients.
The Distribution segment focuses on supplying test, measurement, and control instruments, catering to a wide range of industries. It offers value-added services such as equipment calibration and certification, rentals, used equipment sales, and equipment kitting. The segment employs a multi-channel approach to market its products, including a website, digital and print advertising, outbound sales teams, and an inbound call center. This diversified strategy ensures that Transcat effectively meets the varying needs of its customer base.
Transcat primarily serves highly regulated industries, with a significant focus on the life sciences sector. This includes pharmaceutical, biotechnology, medical device companies, and other FDA-regulated entities. Beyond life sciences, the company also supports aerospace and defense, industrial manufacturing, energy, and utilities. These industries rely on precise processes and equipment calibration, making Transcats services and products essential for maintaining operational integrity and compliance.
Transcat, Inc. has been in operation since its incorporation in 1964 and is headquartered in Rochester, New York. The company is publicly traded under the ticker symbol TRNS on the NASDAQ exchange. For more information, visit their official website at https://www.transcat.com.
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Trading Companies & Distributors
Last Price: 79.15
SMA 20: 81.37
SMA 50: 77.01
SMA 200: 102.17
ATR: 3.81
P/E: 42.23
P/E Forward: 37.31
P/B: 2.66
P/S: 2.71
RoE: 6.53
Based on the provided data, Transcats stock is currently trading slightly below its 20-day moving average, indicating short-term weakness. However, the forward P/E suggests investor confidence in future growth. The companys market cap and P/S ratio reflect its established position in the industry. With a moderate ATR, volatility is manageable, making TRNS a stable pick for investors seeking exposure to the calibration and measurement services sector.
Additional Sources for TRNS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRNS Stock Overview
Market Cap in USD | 743m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Trading Companies & Distributors |
IPO / Inception | 1990-03-27 |
TRNS Stock Ratings
Growth Rating | 45.8 |
Fundamental | 18.9 |
Dividend Rating | 0.0 |
Rel. Strength | -38 |
Analysts | 3.6/5 |
Fair Price Momentum | 76.63 USD |
Fair Price DCF | 25.64 USD |
TRNS Dividends
No Dividends PaidTRNS Growth Ratios
Growth Correlation 3m | 10.5% |
Growth Correlation 12m | -85.3% |
Growth Correlation 5y | 83.6% |
CAGR 5y | 22.50% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | -0.21 |
Alpha | -43.33 |
Beta | 1.242 |
Volatility | 40.23% |
Current Volume | 58.5k |
Average Volume 20d | 91.2k |
As of May 09, 2025, the stock is trading at USD 79.35 with a total of 58,507 shares traded.
Over the past week, the price has changed by -0.38%, over one month by +6.98%, over three months by +1.89% and over the past year by -31.13%.
Neither. Based on ValueRay Fundamental Analyses, Transcat is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of May 2025 is 76.63. This means that TRNS is currently overvalued and has a potential downside of -3.43%.
Transcat has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold TRNS.
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TRNS Transcat will be worth about 87 in May 2026. The stock is currently trading at 79.35. This means that the stock has a potential upside of +9.69%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 100.2 | 26.2% |
Analysts Target Price | 100.2 | 26.2% |
ValueRay Target Price | 87 | 9.7% |